Core Insights - Cannabix Technologies Inc. has launched new product videos for its Marijuana Breath Test (MBT) solution, emphasizing its advanced features and benefits for workplace safety and law enforcement [1][2] - The U.S. Administration's executive order to reclassify marijuana to Schedule III under the Controlled Substances Act highlights the increasing liberalization of cannabis use, creating a demand for Cannabix's MBT solution [1] Product Overview - The MBT system utilizes proprietary Breath Collection Unit and Breath Cartridge technologies to collect and preserve breath samples for analysis using liquid chromatography-mass spectrometry (LC-MS) methods [2] - Cannabix has partnered with Omega Laboratories Inc., a leader in forensic drug testing, to advance the commercialization of the MBT system in the U.S. and Canada [2] Marketing Strategy - The launch of the product videos is a significant step in Cannabix's marketing strategy, providing stakeholders with visuals and key features of the MBT technology [2] - The videos can be accessed through Cannabix's official website, showcasing the technology's role in addressing the need for THC breath detection [2]

Group 1 - Cannabix Technologies Inc. has appointed William R. Corl to its board of directors, who is the CEO of Omega Laboratories, a leading drug testing laboratory [1][2] - Cannabix and Omega have been collaborating since May 2024 to commercialize the Marijuana Breath Test (MBT) technology [1][5] - Omega Laboratories has over twenty years of experience in forensic drug testing and holds multiple international certifications [4] Group 2 - Mr. Corl has extensive experience in technology management and has been influential in advancing drug screening regulations [2][3] - The partnership between Cannabix and Omega includes efforts in marketing, distribution, and logistics for the MBT [5] - Cannabix focuses on developing breath testing technologies for recent marijuana use and has also created an alcohol screening device [6]